ResearcherKitasato UniversityNo recent work listed
Tetsuhiko Shirasaka
Matched on OpenAlex author ID A5113793342. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 25
2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper
Papers 2
- Multicenter, randomized, open-label Phase II study comparing S-1 alternate-day oral therapy with the standard daily regimen as a first-line treatment in patien… Last author DOI 10.1007/s00280-017-3250-8↗
- Phase II clinical study of alternate-day oral therapy with S-1 as first-line chemotherapy for locally advanced and metastatic pancreatic cancer. Last author DOI 10.1007/s00280-013-2323-6↗
Closest collaborators
The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hiroaki Yanagimoto · 2 shared papers, 2014–2017 · strength 0.08
- Paper Multicenter, randomized, open-label Phase II study comparing S-1 alternate-day oral therapy with the standard daily reg… DOI 10.1007/s00280-017-3250-8↗
- Paper Phase II clinical study of alternate-day oral therapy with S-1 as first-line chemotherapy for locally advanced and meta… DOI 10.1007/s00280-013-2323-6↗
- Hiroki Yamaue · 2 shared papers, 2014–2017 · strength 0.08
- Paper Multicenter, randomized, open-label Phase II study comparing S-1 alternate-day oral therapy with the standard daily reg… DOI 10.1007/s00280-017-3250-8↗
- Paper Phase II clinical study of alternate-day oral therapy with S-1 as first-line chemotherapy for locally advanced and meta… DOI 10.1007/s00280-013-2323-6↗
- Shoji Nakamori · 1 shared paper, 2017 · strength 0.05
- Shinichi Ohkawa · 1 shared paper, 2017 · strength 0.05
- Atsushi Shimizu · 1 shared paper, 2017 · strength 0.05
- Hiroshi Ishii · 1 shared paper, 2017 · strength 0.05
- Hiroyuki Isayama · 1 shared paper, 2017 · strength 0.05
- Masayuki Sho · 1 shared paper, 2017 · strength 0.05
- Daisuke Hashimoto · 1 shared paper, 2017 · strength 0.05
- Hideki Ueno · 1 shared paper, 2017 · strength 0.05
- Hiroshi Imaoka · 1 shared paper, 2017 · strength 0.05
- Yasuo Ohashi · 1 shared paper, 2017 · strength 0.05
- Yasuhiro Hagiwara · 1 shared paper, 2017 · strength 0.05
- Masayuki Kitano · 1 shared paper, 2017 · strength 0.05
- Kazuo Chijiiwa · 1 shared paper, 2014 · strength 0.03
- Taketo Yamaguchi · 1 shared paper, 2014 · strength 0.03
- Sohei Satoi · 1 shared paper, 2014 · strength 0.03
- Shinichi Egawa · 1 shared paper, 2014 · strength 0.03
- Jun Kato · 1 shared paper, 2014 · strength 0.03
- Ken‐ichi Okada · 1 shared paper, 2014 · strength 0.03
- Motoki Miyazawa · 1 shared paper, 2014 · strength 0.03
- Seiko Hirono · 1 shared paper, 2014 · strength 0.03
- A‐Hon Kwon · 1 shared paper, 2014 · strength 0.03
- Masaji Tani · 1 shared paper, 2014 · strength 0.03
- Manabu Kawai · 1 shared paper, 2014 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.